4
Changes in Ownership
bioAffinity Technologies, Inc. Filed Acc 0001493152-22-033932
Chief Financial Officer bought 2,448 shares
- Chief Financial Officer acquired 2,243 shares (conversion)
- Chief Financial Officer acquired 3,619 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Edwards James Michael · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-01 | Purchase : show line 1 in the form | +2,448 | 30,323 | D | ||
| 2022-09-06 | Conversion : show line 2 in the form | +2,243 | $4.20 | $9,421 | 32,566 | D |
| 2022-11-17 | Grant or award : show line 3 in the form | +3,619 | 36,815 | D | ||
| Open-market purchases · 2,448 sh | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-01 | Purchase : show line 4 in the form Warrants (right to buy) | +2,448 | 2,448 | D |
| 2022-09-01 | Purchase : show line 5 in the form Non-tradeable Warrants (right to buy) | +2,448 | 2,448 | D |
| 2022-09-06 | Conversion : show line 6 in the form Secured Convertible Promissory Note | −0 | 0 | D |
| 2022-09-06 | Grant or award : show line 7 in the form Warrant (right to buy) | +1,903 | 1,903 | D |
| 2022-07-20 | Grant or award : show line 8 in the form Warrant (right to buy) | +761 | 761 | D |
Loading xslF345X03/ownership.xml…